Dabigatran Market Report

Global and Europe Dabigatran Market Professional Survey Report 2019

  • POSTDATE：Jun 16, 2020
  • PAGES：171
  • REPORT CODE：GMM547348
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Dabigatran market was valued at XX.0 million US$ in 2018, with the CAGR of 4.2%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Dabigatran market. Describe product range of Dabigatran, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Dabigatran market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Dabigatran market.

     

    By Player

    • GlaxoSmithKline

    • Bayer Healthcare

    • Teva Pharmaceutical Industries

    • Pfizer

    • Boehringer Ingelheim

    • Bristol-Myers Squibb Company

    • Aspen Holdings

    By Type

    • Tablets

    • Capsule

    • Others

    By End-User

    • Deep vein thrombosis

    • Pulmonary embolism

    • Others

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dabigatran Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Dabigatran Market Size and Growth Rate of Tablets from 2014 to 2026

      • 1.3.2 Global Dabigatran Market Size and Growth Rate of Capsule from 2014 to 2026

      • 1.3.3 Global Dabigatran Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Dabigatran Market Size and Growth Rate of Deep vein thrombosis from 2014 to 2026

      • 1.4.2 Global Dabigatran Market Size and Growth Rate of Pulmonary embolism from 2014 to 2026

      • 1.4.3 Global Dabigatran Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Dabigatran Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Dabigatran Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Dabigatran Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Dabigatran Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Dabigatran Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dabigatran by Major Types

      • 3.4.1 Dabigatran Market Size and Growth Rate of Tablets

      • 3.4.2 Dabigatran Market Size and Growth Rate of Capsule

      • 3.4.3 Dabigatran Market Size and Growth Rate of Others

    4 Segmentation of Dabigatran Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dabigatran by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Dabigatran for Deep vein thrombosis

      • 4.4.2 Market Size and Growth Rate of Dabigatran for Pulmonary embolism

      • 4.4.3 Market Size and Growth Rate of Dabigatran for Others

    5 Market Analysis by Major Regions

    • 5.1 Global Dabigatran Production Analysis by Top Regions

    • 5.2 Global Dabigatran Consumption Analysis by Top Regions

    • 5.3 Global Dabigatran Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Dabigatran Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Dabigatran Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Dabigatran Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Dabigatran Production, Import, Consumption and Export Analysis

    6 Product Circulation of Dabigatran Market among Top Countries

    • 6.1 Top 5 Export Countries in Dabigatran Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Dabigatran Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Dabigatran Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Dabigatran Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Dabigatran Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Dabigatran Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Dabigatran Landscape Analysis

    • 7.1 North America Dabigatran Landscape Analysis by Top Countries

      • 7.1.1 United States Dabigatran Market Volume and Growth Rate

      • 7.1.2 Canada Dabigatran Market Volume and Growth Rate

      • 7.1.3 Mexico Dabigatran Market Volume and Growth Rate

    8. Europe Dabigatran Landscape Analysis

    • 8.1 Europe Dabigatran Landscape Analysis by Major Types

    • 8.2 Europe Dabigatran Landscape Analysis by Major End-Users

    • 8.3 Europe Dabigatran Landscape Analysis by Top Countries

      • 8.3.1 Germany Dabigatran Market Volume and Growth Rate

      • 8.3.2 UK Dabigatran Market Volume and Growth Rate

      • 8.3.3 France Dabigatran Market Volume and Growth Rate

      • 8.3.4 Italy Dabigatran Market Volume and Growth Rate

      • 8.3.5 Spain Dabigatran Market Volume and Growth Rate

      • 8.3.6 Belgium Dabigatran Market Volume and Growth Rate

      • 8.3.7 Poland Dabigatran Market Volume and Growth Rate

      • 8.3.8 Russia Dabigatran Market Volume and Growth Rate

      • 8.3.9 Turkey Dabigatran Market Volume and Growth Rate

      • 8.3.10 Netherlands Dabigatran Market Volume and Growth Rate

      • 8.3.11 Portugal Dabigatran Market Volume and Growth Rate

      • 8.3.12 Denmark Dabigatran Market Volume and Growth Rate

      • 8.3.13 Finland Dabigatran Market Volume and Growth Rate

      • 8.3.14 Iceland Dabigatran Market Volume and Growth Rate

      • 8.3.15 Norway Dabigatran Market Volume and Growth Rate

      • 8.3.16 Sweden Dabigatran Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Dabigatran Landscape Analysis

    • 9.1 Asia Pacific Dabigatran Landscape Analysis by Top Countries

      • 9.1.1 China Dabigatran Market Volume and Growth Rate

      • 9.1.2 Japan Dabigatran Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Dabigatran Market Volume and Growth Rate

      • 9.1.4 India Dabigatran Market Volume and Growth Rate

      • 9.1.5 ASEAN Dabigatran Market Volume and Growth Rate

      • 9.1.6 South Korea Dabigatran Market Volume and Growth Rate

    10 LAMEA Dabigatran Landscape Analysis

    • 10.1 LAMEA Dabigatran Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Dabigatran Market Volume and Growth Rate

      • 10.1.2 Brazil Dabigatran Market Volume and Growth Rate

      • 10.1.3 North Africa Dabigatran Market Volume and Growth Rate

      • 10.1.4 South Africa Dabigatran Market Volume and Growth Rate

      • 10.1.5 Argentina Dabigatran Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Bayer Healthcare

      • 11.2.1 Bayer Healthcare Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Teva Pharmaceutical Industries

      • 11.3.1 Teva Pharmaceutical Industries Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Boehringer Ingelheim

      • 11.5.1 Boehringer Ingelheim Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Bristol-Myers Squibb Company

      • 11.6.1 Bristol-Myers Squibb Company Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Aspen Holdings

      • 11.7.1 Aspen Holdings Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 96 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Dabigatran Market Size and Growth Rate of Tablets from 2014 to 2026

    • Figure Dabigatran Market Size and Growth Rate of Capsule from 2014 to 2026

    • Figure Dabigatran Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Global Dabigatran Market Size and Growth Rate of Deep vein thrombosis from 2014 to 2026

    • Figure Global Dabigatran Market Size and Growth Rate of Pulmonary embolism from 2014 to 2026

    • Figure Global Dabigatran Market Size and Growth Rate of Others from 2014 to 2026

    • Figure North America Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure United States Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure UK Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure France Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure China Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure India Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Dabigatran Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Dabigatran Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Dabigatran

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dabigatran by Different Types from 2014 to 2026

    • Table Consumption Share of Dabigatran by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Tablets

    • Figure Market Size and Growth Rate of Capsule

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Dabigatran by Different End-Users from 2014 to 2026

    • Table Consumption Share of Dabigatran by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Deep vein thrombosis

    • Figure Market Size and Growth Rate of Pulmonary embolism

    • Figure Market Size and Growth Rate of Others

    • Table Global Dabigatran Production by Major Regions

    • Table Global Dabigatran Production Share by Major Regions

    • Table Global Dabigatran Consumption by Major Regions

    • Table Global Dabigatran Consumption Share by Major Regions

    • Table North America Dabigatran Production, Import, Consumption and Export Analysis

    • Table Europe Dabigatran Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Dabigatran Production, Import, Consumption and Export Analysis

    • Table LAMEA Dabigatran Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Dabigatran Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Dabigatran Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Dabigatran Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Dabigatran Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Dabigatran Consumption by Major Countries from 2014 to 2026

    • Table North America Dabigatran Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Dabigatran Consumption Share by Major Countries in 2014

    • Figure North America Dabigatran Consumption Share by Major Countries in 2018

    • Figure North America Dabigatran Consumption Share by Major Countries in 2026

    • Figure United States Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Dabigatran Consumption by Types from 2014 to 2026

    • Table Europe Dabigatran Consumption Share by Types from 2014 to 2026

    • Table Europe Dabigatran Consumption by End-Users from 2014 to 2026

    • Table Europe Dabigatran Consumption Share by End-Users from 2014 to 2026

    • Table Europe Dabigatran Consumption by Major Countries from 2014 to 2026

    • Table Europe Dabigatran Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure France Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Dabigatran Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Dabigatran Consumption Share by Major Countries from 2014 to 2026

    • Figure China Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure India Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Dabigatran Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Dabigatran Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Dabigatran Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Bayer Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare

    • Figure Revenue and Market Share Analysis of Bayer Healthcare

    • Table Product and Service Introduction of Bayer Healthcare

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of Aspen Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen Holdings

    • Figure Sales and Growth Rate Analysis of Aspen Holdings

    • Figure Revenue and Market Share Analysis of Aspen Holdings

    • Table Product and Service Introduction of Aspen Holdings

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US